The significance of LMO2 expression in the progression of prostate cancer

Journal of Pathology

Volumn 211, Issue 3, 2007, Pages 278-285

  Ma, S ^a   Guan, X Y ^a   Beh, P S L ^a   Wong, K Y ^a   Chan, Y P ^a   Yuen, H F ^a   Vielkind, J ^b,c   Chan, K W ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

E cadherin; LMO2; Metastasis; Prostate cancer

Indexed keywords

ANDROGEN; LIM PROTEIN; LMO2 PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FATE; CELL GROWTH; CELL MOTILITY; CELL STRAIN LNCAP; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC REGULATION; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TUMOR XENOGRAFT;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL LINE, TUMOR; CHI-SQUARE DISTRIBUTION; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; METALLOPROTEINS; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33846563501     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2109     Document Type: Article

References (22)

1. Rizzo S, Attard G, Hudson DL. Prostate epithelial stem cells. Cell Prolif 2005;38:363-374.
2. Boehm T, Foroni L, Kaneko Y, Perutz MF, Rabbitts TH. The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc Natl Acad Sci U S A 1991;88:4367-4371.
3. Royer-Pokora B, Rogers M, Zhu TH, Schneider S, Loos U, Bolitz U. The TTG-2/RBTN2 T cell oncogene encodes two alternative transcripts from two promoters: the distal promoter is removed by most 11p13 translocations in acute T cell leukaemias (T-ALL). Oncogene 1995;10:1353-1360.
4. Rabbitts TH. LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes. Genes Dev 1998;12:2651-2657.
5. Fisch P, Boehm T, Lavenir I, Larson T, Arno J, Forster A. T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTNI and RBTN2 LIM-domain genes. Oncogene 1992;7:2389-2397.
6. McGuire EA, Rintoul CE, Sclar GM, Korsmeyer SJ. Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukernia/ lymphoma. Mol Cell Biol 1992;12:4186-4196.
7. Neale GA, Rehg JE, Goorha RM. Disruption of T-cell differentiation precedes T-cell tumour formation in LMO-2 (rhombotin-2) transgenic mice. Leukemia 1997;3:289-290.
8. Yamada Y, Pannell R, Forster A, Rabbitts TH. The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target. Oncogene 2002;21:1309-1315.
9. Dawid IB, Toyama R, Taira M. LIM domain proteins. C R Acad Sci III 1995;318:295-306.
10. Dawid IB, Breen JJ, Toyama R. LIM domains: multiple roles as adaptors and functional modifiers in protein interactions. Trends Genet 1998;14:156-162.
11. Sanchez-Garcia I, Rabbits TH. The LIM domain: a new structural motif found in zinc-finger-like proteins. Trends Genet 1994;10:315-320.
12. Nagabhushan M, Miller CM. CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res 1996;56:3042-3046.
13. Webber MM, Bello D, Quader S. Immortalized and tumourigenic adult human prostatic epithelial cell lines: characteristics and applications. Part 2. Tumourigenic cell lines. Prostate 1997;30:58-64.
14. Wadman IA, Osada H, Grutz GG, Agulnick AD, Westphal H, Forster A. The LIM-only protein LMO2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NL1 proteins. EMBO J 1997;16:3145-3157.
15. Han C, Liu H, Liu J, Yin K, Xie Y, Shen X. Human Bex2 interacts with LMO2 and regulates the transcriptional activity of a novel DNA-binding complex. Nucleic Acids Res 2005;33:6555-6565.
16. Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HF, Schaafsma HE. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 1992;52:5104-5109.
17. Umbas R, Isaacs WB, Bringuier PP, Schaafsma. HE, Karthaus HF, Oosterhof GO. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 1994;54:3929-3933.
18. Birchmeier W, Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochem Biophys Acta 1994;1198:11-26.
19. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998;153:333-339.
20. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci U S A 1995;9:7416-7419.
21. Peinado H, Portillo F, Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 2004;48:365-375.
22. Nieto MA. The snail superfamily of zinc-finger transcription factor. Nature Rev Mol Cell Biol 2002;3:155-166.